Loading…
Vera Therapeutics, Inc. is projected to rise to $43.20 by 2027, a +26% move from its current price of $34.27. VERA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $33.33 | $34.26 | $35.21 | -0.04% |
| May 30 | $32.94 | $34.24 | $35.60 | -0.08% |
| May 31 | $32.64 | $34.23 | $35.90 | -0.12% |
| Jun 1 | $32.38 | $34.21 | $36.15 | -0.17% |
| Jun 2 | $32.16 | $34.20 | $36.37 | -0.21% |
| Jun 3 | $31.96 | $34.18 | $36.56 | -0.25% |
| Jun 4 | $31.77 | $34.17 | $36.75 | -0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $31.77 | $34.17 | $36.75 | -0.29% |
| Week 2 | $30.74 | $34.07 | $37.76 | -0.58% |
| Week 3 | $29.95 | $33.97 | $38.53 | -0.87% |
| Week 4 | $29.29 | $33.87 | $39.17 | -1.16% |
| Week 5 | $28.71 | $33.78 | $39.74 | -1.44% |
| Week 6 | $28.18 | $33.68 | $40.24 | -1.73% |
| Week 7 | $27.70 | $33.58 | $40.70 | -2.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. Vera Therapeutics, Inc.
was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Vera Therapeutics, Inc. trades as a healthcare stock with a current price of $34.04 per share and a market capitalization of $2.44B, ranking 1873 by market cap. The near-term outlook is neutral, with a 2026 forecast showing an average price of $34.04, a minimum of $33.25, and a maximum of $44.16, and a 0% ROI.
The forecast progresses to a bullish tone in subsequent years, with rising average targets and meaningful upside through 2050.
A major floor 21.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (3.0% away) — a key level to hold.
The nearest ceiling, 26.8% above — a clean break opens room to run.
A major ceiling 42.2% above — clearing it would confirm fresh momentum.
Key VERA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VERA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $34.32 | Sell | $34.45 | Sell |
| MA 10 | $35.53 | Sell | $35.01 | Sell |
| MA 20 | $35.70 | Sell | $35.98 | Sell |
| MA 50 | $38.56 | Sell | $37.97 | Sell |
| MA 100 | $41.19 | Sell | $38.67 | Sell |
| MA 200 | $36.25 | Sell | $37.02 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.01 | Neutral |
| Stoch RSI (14) | 24.89 | Neutral |
| CCI (20) | -75.48 | Neutral |
| Williams %R (14) | -83.84 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | -5.31 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 16.16 | Buy |
| TRIX (15) | -0.45 | Sell |
| Awesome (5,34) | -3.57 | Sell |
| Ultimate (7,14,28) | 31.44 | Neutral |
| Momentum (10) | -2.43 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 33.84 | Buy |
| ADX (14) | 19.82 | Neutral |
| ATR (14) | 0.88 | Info |
In the next 30 days, the technical picture remains NEUTRAL with RSI(14) at 40. The SMA50 is $38.79 and the SMA200 is $36.10, indicating the price is oscillating around key moving averages. The security shows a defined 30-day range from $28.09 to $41.25, with a support level at $33.25 and a resistance level at $44.36.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $33.25 | $34.27 | $44.69 | 0% | Neutral | |
| $34.24 | $43.20 | $57.75 | +26% | Bullish | |
| $35.31 | $45.78 | $63.44 | +34% | Bullish | |
| $35.28 | $46.80 | $66.72 | +37% | Bullish | |
| $36.04 | $48.79 | $71.25 | +42% | Bullish | |
| $35.57 | $49.06 | $73.16 | +43% | Bullish | |
| $39.62 | $55.60 | $84.50 | +62% | Bullish | |
| $45.07 | $64.28 | $99.37 | +88% | Bullish | |
| $47.72 | $69.12 | $108.55 | +102% | Bullish | |
| $50.77 | $74.64 | $118.96 | +118% | Bullish | |
| $65.27 | $102.63 | $173.96 | +199% | Bullish | |
| $97.50 | $172.22 | $319.38 | +403% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $33.25 | $34.27 | $40.13 | +0.00% |
| June 2026 | $28.13 | $33.04 | $39.74 | -3.58% |
| July 2026 | $27.86 | $33.00 | $40.22 | -0.15% |
| August 2026 | $28.20 | $33.63 | $41.42 | +1.91% |
| September 2026 | $27.54 | $33.02 | $41.02 | -1.79% |
| October 2026 | $27.11 | $32.67 | $40.89 | -1.08% |
| November 2026 | $28.16 | $34.09 | $42.96 | +4.34% |
| December 2026 | $29.00 | $35.24 | $44.69 | +3.39% |
Click any year to see its month-by-month VERA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VERA price prediction for 2026 points to an average of $34.27 (low $33.25, high $44.69) — a potential gain of 0% on today's $34.27. A consolidation phase looks the most probable path here.
In 2027, VERA is projected to trade between $34.24 and $57.75, averaging $43.20 — a potential gain of +26% from today's $34.27. That is up +26% on the projected 2026 average. Momentum favours further upside here.
Vera Therapeutics, Inc.'s 2028 outlook centres on $45.78, within a $35.31 to $63.44 range. That is up +6% on the projected 2027 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, VERA could reach as high as $66.72, with a base case around $46.80 and support toward $35.28 — roughly +37% from $34.27. Momentum favours further upside here.
Expect VERA to range from $36.04 to $71.25 through 2030. The $48.79 average target implies a +42% move from current prices. That is up +4% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The VERA price prediction for 2031 points to an average of $49.06 (low $35.57, high $73.16) — a potential gain of +43% on today's $34.27. Momentum favours further upside here.
In 2032, VERA is projected to trade between $39.62 and $84.50, averaging $55.60 — a potential gain of +62% from today's $34.27. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Vera Therapeutics, Inc.'s 2033 outlook centres on $64.28, within a $45.07 to $99.37 range. That is up +16% on the projected 2032 average. That marks a +88% change versus current levels. Momentum favours further upside here.
By 2034, VERA could reach as high as $108.55, with a base case around $69.12 and support toward $47.72 — roughly +102% from $34.27. Buyers look set to stay in control over this stretch.
Expect VERA to range from $50.77 to $118.96 through 2035. The $74.64 average target implies a +118% move from current prices. That is up +8% on the projected 2034 average. Momentum favours further upside here.
The VERA price prediction for 2040 points to an average of $102.63 (low $65.27, high $173.96) — a potential gain of +199% on today's $34.27. Buyers look set to stay in control over this stretch.
In 2050, VERA is projected to trade between $97.50 and $319.38, averaging $172.22 — a potential gain of +403% from today's $34.27. That is up +68% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in VERA today (≈ 29.180041 VERA) could be worth
$5,025.39
+$4,025.39 (+403%) by 2050 · US Dollar
Based on the average projected VERA price of $172.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VERAwould be worth at today's price.
$1,000 invested in VERA on May 27, 2025 (≈ 52.521006 VERA) would be worth
$1,799.89
+$799.89 (+80.0%) today · 1.80× · US Dollar
Based on a VERA entry price of $19.04 vs. today's $34.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $34.62 | $989.89 | -1.0% |
| 1 month ago | $37.28 | $919.26 | -8.1% |
| 3 months ago | $42.35 | $809.21 | -19.1% |
| 6 months ago | $33.75 | $1,015.41 | +1.5% |
| 1 year ago | $19.04 | $1,799.89 | +80.0% |
| All time (5.0y) ago | $15.55 | $2,203.86 | +120.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VERA forecast.
Our base-case forecast reaches $69.00 around 2034.
Implied market cap at $69.00: $4.95B
The multi-year forecast shows a bullish trajectory beginning in 2027, with an average price of $42.37 and a max of $57.13 (ROI 24.5%), followed by 2028 at $45.09 (max $63.12, ROI 32.5%) and 2029 at $45.29 (max $65.32, ROI 33.1%). By 2030 the average is $47.03 (max $69.56, ROI 38.2%), continuing through 2031 at $47.03 (max $71.10, ROI 38.1%) and 2032 at $52.24 (max $80.55, ROI 53.5%), then 2033 at $60.99 (max $95.74, ROI 79.2%), 2034 at $66.01 (max $105.34, ROI 93.9%), and 2035 at $70.29 (max $113.91, ROI 106.5%). The forecast extends to 2040 with an average of $96.04 (max $165.93, ROI 182.1%) and to 2050 with an average of $156.47 (max $296.80, ROI 359.7%).
These projections are estimates and not guarantees; actual results depend on factors including market conditions and development progress.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $47.03 with a maximum of $69.56 and a projected ROI of 38.2%, indicating bullish potential for that year.
Forecasts show a bullish trajectory from 2027 onward, with rising averages and a potential ROI reaching 359.7% by 2050, but these are estimates and not guarantees; actual results may vary.
Yes. The 2034 max forecast is $105.34 and the 2035 max forecast is $113.91, indicating the price could surpass $100 by 2034–2035.
The current price is $34.04 per share and the market cap is $2.44B, with a market rank of 1873.
The 30-day technical picture shows NEUTRAL sentiment with RSI(14) at 40, SMA50 at $38.79, SMA200 at $36.10, a 30-day range of $28.09 to $41.25, support at $33.25, and resistance at $44.36.
Vera Therapeutics, Inc. Community Discussion
0Share your Vera Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.